These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19804476)

  • 1. Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP.
    Wiesmann M; Steinmeier E; Magerkurth O; Linn J; Gottmann D; Missler U
    Acta Neurol Scand; 2010 Mar; 121(3):178-85. PubMed ID: 19804476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GFAP and S100B in the acute phase of mild traumatic brain injury.
    Metting Z; Wilczak N; Rodiger LA; Schaaf JM; van der Naalt J
    Neurology; 2012 May; 78(18):1428-33. PubMed ID: 22517109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100B is not a reliable prognostic index in paediatric TBI.
    Piazza O; Storti MP; Cotena S; Stoppa F; Perrotta D; Esposito G; Pirozzi N; Tufano R
    Pediatr Neurosurg; 2007; 43(4):258-64. PubMed ID: 17627141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury.
    Nylén K; Ost M; Csajbok LZ; Nilsson I; Hall C; Blennow K; Nellgård B; Rosengren L
    Acta Neurochir (Wien); 2008 Mar; 150(3):221-7; discussion 227. PubMed ID: 18193148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study.
    Vos PE; Jacobs B; Andriessen TM; Lamers KJ; Borm GF; Beems T; Edwards M; Rosmalen CF; Vissers JL
    Neurology; 2010 Nov; 75(20):1786-93. PubMed ID: 21079180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.
    Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H
    J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can serum protein S100beta predict neurological deterioration after moderate or minor traumatic brain injury?].
    Bouzat P; Francony G; Declety P; Brun J; Kaddour A; Renversez JC; Jacquot C; Payen JF
    Ann Fr Anesth Reanim; 2009 Feb; 28(2):135-9. PubMed ID: 19211218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.
    Nylén K; Ost M; Csajbok LZ; Nilsson I; Blennow K; Nellgård B; Rosengren L
    J Neurol Sci; 2006 Jan; 240(1-2):85-91. PubMed ID: 16266720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
    Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
    Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
    Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
    Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of alcohol intoxication on S100B levels following traumatic brain injury.
    Lange RT; Brubacher JR; Iverson GL; Procyshyn RM; Mitrovic S
    J Trauma; 2010 May; 68(5):1065-71. PubMed ID: 20016383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.
    Honda M; Tsuruta R; Kaneko T; Kasaoka S; Yagi T; Todani M; Fujita M; Izumi T; Maekawa T
    J Trauma; 2010 Jul; 69(1):104-9. PubMed ID: 20093985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can S-100B serum protein help to save cranial CT resources in a peripheral trauma centre? A study and consensus paper.
    Müller B; Evangelopoulos DS; Bias K; Wildisen A; Zimmermann H; Exadaktylos AK
    Emerg Med J; 2011 Nov; 28(11):938-40. PubMed ID: 20961930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of glial fibrillary acidic protein during traumatic brain injury in children.
    Zurek J; Fedora M
    J Trauma; 2011 Oct; 71(4):854-9. PubMed ID: 21986734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults.
    Rodríguez-Rodríguez A; Egea-Guerrero JJ; León-Justel A; Gordillo-Escobar E; Revuelto-Rey J; Vilches-Arenas A; Carrillo-Vico A; Domínguez-Roldán JM; Murillo-Cabezas F; Guerrero JM
    Clin Chim Acta; 2012 Dec; 414():228-33. PubMed ID: 23031665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple indicators model of long-term mortality in traumatic brain injury.
    Gradisek P; Osredkar J; Korsic M; Kremzar B
    Brain Inj; 2012; 26(12):1472-81. PubMed ID: 22721420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.
    Geyer C; Ulrich A; Gräfe G; Stach B; Till H
    J Neurosurg Pediatr; 2009 Oct; 4(4):339-44. PubMed ID: 19795965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury.
    Kleindienst A; Meissner S; Eyupoglu IY; Parsch H; Schmidt C; Buchfelder M
    Acta Neurochir Suppl; 2010; 106():247-50. PubMed ID: 19812958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau proteins in serum predict outcome after severe traumatic brain injury.
    Liliang PC; Liang CL; Weng HC; Lu K; Wang KW; Chen HJ; Chuang JH
    J Surg Res; 2010 May; 160(2):302-7. PubMed ID: 19345376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of MR imaging in assessing prognosis after severe and moderate head injury.
    Lagares A; Ramos A; Pérez-Nuñez A; Ballenilla F; Alday R; Gómez PA; Kaen A; Lobato RD
    Acta Neurochir (Wien); 2009 Apr; 151(4):341-56. PubMed ID: 19224121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.